Jorden David Emerson
Nuo Therapeutics, Inc. · CEO/CFO
Jorden David Emerson is listed in filings as CEO/CFO at Nuo Therapeutics, Inc.. This profile follows SEC Form 4 activity through Jun 5, 2026, including sale activity. Recent filings connect the profile to Nuo Therapeutics, Inc. (AURX). The current snapshot covers public activity from Aug 4, 2025 to Jun 5, 2026. Reported amounts are shown as $14.5K to $300.0K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
Latest Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $300k200k shares | SellNov 28, 2025 | $1.50 | $1.00 |